Skip to content
healthcare.dev

Docetaxel

NDC 25021-254, Docetaxel Anhydrous, injection, from Sagent Pharmaceuticals.

Product NDC
25021-254
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-254 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOCETAXEL ANHYDROUS10 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
25021-254-08250210254081 VIAL in 1 CARTON (25021-254-08) / 8 mL in 1 VIAL
25021-254-16250210254161 VIAL in 1 CARTON (25021-254-16) / 16 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b227144-c844-4549-960c-cc3ac5c13b2b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-254

Use it

Look up 25021-254 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-254 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-254. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.